Clinical trial

A Randomised Placebo Controlled Study of OXN PR for Severe Parkinson's Disease Associated Pain

NCT01439100

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Oxycodone/Naloxone Prolonged Release tablets Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

A Randomised Placebo Controlled Study of OXN PR for Severe Parkinson's Disease Associated Pain

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-10-01

PhasePHASE3

Conditions

Parkinson's Disease With Severe Painunresolved

Interventions

Oxycodone/Naloxone Prolonged Release tabletsDRUG

PlaceboDRUG

Sponsors & collaborators

Mundipharma Research GmbH & Co KGlead sponsor

Mapped research locations

BarcelonaSpain2 MadridSpain1 LondonUnited Kingdom1 BudapestHungary1 KrakowPoland1 LeipzigGermany1 BrnoCzechia1 DebrecenHungary1 UlmGermany1 BochumGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01439100 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.